Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Prosonix

Novartis building

Canada and Switzerland lift Novartis flu vaccines ban

Independent tests confirm safety following contamination fears

- PMLiVE

UK Bribery Act: A game changer

The Director of the Serious Fraud Office intends to enforce the Act ‘vigorously’ – it would be wise to take him at his word

UK flag

MRC funds UK research using 22 AstraZeneca compounds

Provides £7m for projects covering Alzheimer’s, cancer, lung disease and rare conditions

- PMLiVE

UK considers greater self-regulation of pharmacies

And MHRA to review sanctions and penalties

Novartis building

France, Germany and Spain join list of countries banning Novartis vaccines

Flu vaccines Agrippal and Fluad withdrawn after some batches found to be contaminated

UK flag

UK could allow patented drugs to be used in clinical trials

Government proposes update to Patents Act to restrict when companies can sue for infringement

EU flag

Europe misses flu vaccine target for at-risk groups

Netherlands only country where coverage is at recommended level, says WHO

UK flag

UK doctors to face annual appraisals

Will need to show they are aware of new advances in medicine

Pilot study combines patient-reported outcomes and medical records

Quintiles concludes patients can be recruited directly for observational studies

- PMLiVE

GSK expands open-source research project in TB

Opens up compound library and extends data transparency project

GSK partners with Aeras on TB vaccine

Will begin phase II trials in Kenya, India and South Africa

- PMLiVE

Pakistan to use GSK’s Synflorix in national pneumococcal vaccination programme

Company will supply it at 90 per cent discount through the GAVI Alliance

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links